Literature DB >> 22633632

Clinical features and neurologic progression of hyperargininemia.

Daniel R Carvalho1, Jaime M Brum, Carlos E Speck-Martins, Fabrício D Ventura, Mônica M M Navarro, Kátia E F A Coelho, Dalton Portugal, Riccardo Pratesi.   

Abstract

Hyperargininemia is an autosomal recessive metabolic disorder caused by a deficiency of enzyme arginase I. It is a rare pan-ethnic disease with a clinical presentation distinct from that of other urea cycle disorders, and hyperammonemic encephalopathy is not usually observed. Hyperargininemia is one of the few treatable causes of pediatric spastic paraparesis, and can be confused with cerebral palsy. We retrospectively evaluated the clinical onset, neurologic manifestations, progression of abnormalities, electroencephalographic abnormalities, and laboratory findings of 16 Brazilian patients with hyperargininemia. Relevant data about the clinical spectrum and natural history of hyperargininemia are detailed. Progressive spastic diplegia constituted the key clinical abnormality in this group, but variability in clinical presentation and progression were evident in our series. Seizures in hyperargininemia may be more common than reported in previous studies. Features distinguishing hyperargininemia from cerebral palsy and hereditary spastic paraplegia are emphasized in this large series of patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22633632     DOI: 10.1016/j.pediatrneurol.2012.03.016

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  12 in total

1.  Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency.

Authors:  Kirtika H Asrani; Lei Cheng; Christopher J Cheng; Romesh R Subramanian
Journal:  RNA Biol       Date:  2018-07-24       Impact factor: 4.652

2.  The effect of liver transplantation for argininemia-the largest experiences in a single center.

Authors:  Bin Cui; Lin Wei; Li-Ying Sun; Wei Qu; Zhi-Gui Zeng; Ying Liu; Zhi-Jun Zhu
Journal:  Transl Pediatr       Date:  2022-04

3.  Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency.

Authors:  Martina Huemer; Daniel R Carvalho; Jaime M Brum; Özlem Ünal; Turgay Coskun; James D Weisfeld-Adams; Nina L Schrager; Sabine Scholl-Bürgi; Andrea Schlune; Markus G Donner; Martin Hersberger; Claudio Gemperle; Brunhilde Riesner; Hanno Ulmer; Johannes Häberle; Daniela Karall
Journal:  J Inherit Metab Dis       Date:  2016-04-01       Impact factor: 4.982

4.  Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.

Authors:  Brian Truong; Gabriella Allegri; Xiao-Bo Liu; Kristine E Burke; Xuling Zhu; Stephen D Cederbaum; Johannes Häberle; Paolo G V Martini; Gerald S Lipshutz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-09       Impact factor: 11.205

5.  Human recombinant arginase enzyme reduces plasma arginine in mouse models of arginase deficiency.

Authors:  Lindsay C Burrage; Qin Sun; Sarah H Elsea; Ming-Ming Jiang; Sandesh C S Nagamani; Arthur E Frankel; Everett Stone; Susan E Alters; Dale E Johnson; Scott W Rowlinson; George Georgiou; Brendan H Lee
Journal:  Hum Mol Genet       Date:  2015-09-10       Impact factor: 6.150

Review 6.  Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue.

Authors:  Kuntal Sen; Afrouz A Anderson; Matthew T Whitehead; Andrea L Gropman
Journal:  Front Neurol       Date:  2021-04-28       Impact factor: 4.086

7.  Argininemia as a cause of severe chronic stunting and partial growth hormone deficiency (PGHD): A case report.

Authors:  Xiaotang Cai; Dan Yu; Yongmei Xie; Hui Zhou
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.817

Review 8.  Childhood-onset hereditary spastic paraplegia and its treatable mimics.

Authors:  Darius Ebrahimi-Fakhari; Afshin Saffari; Phillip L Pearl
Journal:  Mol Genet Metab       Date:  2021-06-24       Impact factor: 4.797

9.  Late onset arginase deficiency presenting with encephalopathy and midbrain hyperintensity.

Authors:  Boby Varkey Maramattom; Rajat Raja; Anuroop Balagopal
Journal:  Ann Indian Acad Neurol       Date:  2016 Jul-Sep       Impact factor: 1.383

10.  A novel compound heterozygous mutation in the arginase-1 gene identified in a Chinese patient with argininemia: A case report.

Authors:  Dongqing Cui; Yanxia Liu; Liang Jin; Liping Hu; Lili Cao
Journal:  Medicine (Baltimore)       Date:  2020-08-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.